Stevanato Group S.p.A. (STVN)
NYSE: STVN · Real-Time Price · USD
19.26
+0.99 (5.42%)
Nov 21, 2024, 1:44 PM EST - Market open

Stevanato Group Revenue

Stevanato Group had revenue of 277.87M EUR in the quarter ending September 30, 2024, with 2.38% growth. This brings the company's revenue in the last twelve months to 1.09B, up 3.53% year-over-year. In the year 2023, Stevanato Group had annual revenue of 1.09B with 10.34% growth.

Revenue (ttm)
1.09B EUR
Revenue Growth
+3.53%
P/S Ratio
4.03
Revenue / Employee
194,192 EUR
Employees
5,634
Market Cap
5.26B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.09B101.67M10.34%
Dec 31, 2022983.68M139.76M16.56%
Dec 31, 2021843.92M181.88M27.47%
Dec 31, 2020662.04M125.50M23.39%
Dec 31, 2019536.54M514.54M2,338.37%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Select Medical Holdings 6.97B
Integer Holdings 1.71B
Waystar Holding 906.14M
ADMA Biologics 382.81M
Krystal Biotech 241.52M
PROCEPT BioRobotics 199.84M
Arcellx 155.82M
Avidity Biosciences 10.12M
Revenue Rankings